...
首页> 外文期刊>Molecular biology of the cell >Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability
【24h】

Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability

机译:IL-8 / CXCL8诱导的内皮通透性需要通过白介素8(IL-8 / CXCL8)来激活血管内皮生长因子受体2

获取原文
获取原文并翻译 | 示例

摘要

Interleukin-8 (IL-8/CXCL8) is a chemokine that increases endothelial permeability during early stages of angiogenesis. However, the mechanisms involved in IL-8/CXCL8-induced permeability are poorly understood. Here, we show that permeability induced by this chemokine requires the activation of vascular endothelial growth factor receptor-2 (VEGFR2/fetal liver kinase 1/KDR). IL-8/CXCL8 stimulates VEGFR2 phosphorylation in a VEGF-independent manner, suggesting VEGFR2 transactivation. We investigated the possible contribution of physical interactions between VEGFR2 and the IL-8/CXCL8 receptors leading to VEGFR2 transactivation. Both IL-8 receptors interact with VEGFR2 after IL-8/CXCL8 treatment, and the time course of complex formation is comparable with that of VEGFR2 phosphorylation. Src kinases are involved upstream of receptor complex formation and VEGFR2 transactivation during IL-8/CXCL8-induced permeability. An inhibitor of Src kinases blocked IL-8/CXCL8-induced VEGFR2 phosphorylation, receptor complex formation, and endothelial permeability. Furthermore, inhibition of the VEGFR abolishes RhoA activation by IL-8/CXCL8, and gap formation, suggesting a mechanism whereby VEGFR2 transactivation mediates IL-8/CXCL8-induced permeability. This study points to VEGFR2 transactivation as an important signaling pathway used by chemokines such as IL-8/CXCL8, and it may lead to the development of new therapies that can be used in conditions involving increases in endothelial permeability or angiogenesis, particularly in pathological situations associated with both IL-8/CXCL8 and VEGF.
机译:白介素8(IL-8 / CXCL8)是一种趋化因子,可在血管生成的早期增加内皮的通透性。但是,有关IL-8 / CXCL8诱导的通透性的机制了解甚少。在这里,我们表明这种趋化因子诱导的通透性需要激活血管内皮生长因子受体2(VEGFR2 /胎儿肝激酶1 / KDR)。 IL-8 / CXCL8以VEGF非依赖性方式刺激VEGFR2磷酸化,提示VEGFR2反式激活。我们调查了VEGFR2和IL-8 / CXCL8受体之间导致VEGFR2反式激活的物理相互作用的可能贡献。 IL-8 / CXCL8处理后,两种IL-8受体均与VEGFR2相互作用,并且复合物形成的时间过程与VEGFR2磷酸化的过程相当。在IL-8 / CXCL8诱导的通透性过程中,Src激酶参与受体复合物形成和VEGFR2反式激活的上游。 Src激酶抑制剂可阻止IL-8 / CXCL8诱导的VEGFR2磷酸化,受体复合物形成和内皮通透性。此外,对VEGFR的抑制消除了IL-8 / CXCL8对RhoA的激活和间隙的形成,提示了VEGFR2反式激活介导IL-8 / CXCL8诱导的通透性的机制。这项研究指出,VEGFR2反式激活是趋化因子(如IL-8 / CXCL8)使用的重要信号通路,它可能导致开发出新疗法,可用于涉及内皮通透性增加或血管生成的疾病,特别是在病理情况下与IL-8 / CXCL8和VEGF相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号